The Global Health Body Sounds Alert Over Acute Scarcity of Obesity Medications
Under one in 10 people that would benefit from obesity jabs such as Wegovy have access to them, warns the World Health Organization as it releases its inaugural advice on the therapies.
Given in excess of 1,000,000,000 individuals worldwide currently classified as obese, it is urging increased and just access to this class of drugs.
Based on forecasts, more than two billion are projected to be obese by 2030 unless action is taken.
"Our new guidelines recognises that excess weight is a chronic disease that can be treated with comprehensive and continuous support," said its chief Tedros Adhanom Ghebreyesus.
Substantial prices, constrained manufacturing, and distribution challenges are key obstacles to broad availability to the treatments that can aid individuals in losing significant body mass, says the organization.
GLP-1 Therapy Supply Crisis
Even under the present most favorable case, the production of these medications might only reach approximately 100 million people – less than 10% of eligible patients, as stated by the health organization.
The recommendation calls on nations and manufacturers to expand availability, via approaches such as voluntary licensing.
The intellectual property rights on a key compound – the main ingredient of a leading brand – is set to lapse in a number of countries in 2026.
How Weight-Loss Drugs Work
The injections replicate a biological compound to delay gastric emptying, suppress the appetite and increase feelings of fullness so users reduce food intake.
Patients commonly start to lose weight after several weeks of starting on the once-weekly jabs.
Studies indicates people may see weight return within a year of stopping the medication, as their typical appetite come back.
Being above a healthy weight raises your risk for experiencing diseases, such as type 2 diabetes, cardiovascular issues, stroke, and some cancers.
Excess weight affects people in countries worldwide and was linked to over three and a half million fatalities worldwide in 2024, according to the WHO.
